Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Norway Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20072
20082
20091
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S4
Tranzyme, Inc.2
Asker & Baerum Hospital1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1
Solvay Pharmaceuticals1
University of Tromso1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus11
Diabetes Mellitus, Type 25
Diabetes Mellitus, Type 12
Gastroparesis2
Metabolic Syndrome2
Body Weight1
Diabetic Foot1
Endocrine System Diseases1
Foot Ulcer1
Heart Failure1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.